Lynn Seely Insider Profile
11 Followers
Lynn Seely, President & CEO, Director at Lyell Immunopharma, holds 63.90K shares in Lyell Immunopharma (Ticker: LYEL), holds ― shares in AbCellera Biologics (Ticker: ABCL), holds 0.00 shares in Blueprint Medicines (Ticker: BPMC). Most recently, Lynn Seely Sold ― shares of Lyell Immunopharma on Aug 25, 2026 for an estimated value of $149.01K.
Lynn Seely Lyell Immunopharma (LYEL)President & CEO, Director
Lyell Immunopharma (LYEL)
President & CEO, Director
Ranked #30,396 out of 108,921 Corporate Insiders
Profitable Transactions
6 out of 10 Profitable Transactions
Average Return
+3.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lynn Seely holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lynn Seely
Lynn Seely's Trading History
Lyell Immunopharma
Aug 25, 2026
President & CEO, Director
Informative Sell
149.01K
$823.02K
AbCellera Biologics
―
Director
―
―
Medivation
Feb 10, 2015
―
Uninformative Buy
―
$7.81M
Blueprint Medicines
Jul 21, 2025
―
Uninformative Sell
―
$0.00
Myovant Sciences
Apr 07, 2020
―
Uninformative Buy
―
$50.99M
List of latest transactions for each holding click on a transaction to see Lynn Seely's performance on stock
You May Also Like
Lynn Seely insider profile FAQ
What is the percentage of profitable transactions made by Lynn Seely?
The percentage of profitable transactions made by Lynn Seely is 60%.
What is the average return per transaction made by Lynn Seely?
The average return per transaction made by Lynn Seely is 3.90%.
What stocks does Lynn Seely hold?
Lynn Seely holds: LYEL, ABCL, MDVN, BPMC, MYOV stocks.
What was Lynn Seely’s latest transaction?
Lynn Seely latest transaction was an Informative Sell of $149.01K.
What was Lynn Seely's most profitable transaction?
Lynn Seely’s most profitable transaction was an Informative Sell of LYEL stock on February 12, 2026. The return on the trade was 43.30%.
What is Lynn Seely's role in Lyell Immunopharma?
Lynn Seely's role in Lyell Immunopharma is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.